Arkolith/Insider Trading/ADIL/Form 4

Schuyler Kevin

DirectorADIAL PHARMACEUTICALS, INC. (ADIL) · full profile →Form 4 · filed Nov 25, 2020
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
0 non-derivative · 12 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 23, 2020Gift(G)1K——1K
Nov 23, 2020Gift(G)9K——9K
Nov 23, 2020Gift(G)90K——90K
Nov 23, 2020Gift(G)90K——90K
Nov 23, 2020Gift(G)82K——82K
Nov 23, 2020Gift(G)90K——90K
Nov 23, 2020Gift(G)1K——0
Nov 23, 2020Gift(G)9K——0
Nov 23, 2020Gift(G)90K——0
Nov 23, 2020Gift(G)90K——0
Nov 23, 2020Gift(G)82K——0
Nov 23, 2020Gift(G)90K——0

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-20-039336) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ADIAL PHARMACEUTICALS, INC.

Build

Ask your agent about ADIL insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001213900-20-039336"
Ask your agent
Use Arkolith to summarize insider buying and selling at ADIAL PHARMACEUTICALS, INC.
over the last 90 days and cite the filings.